CClinicalTrials.gg
Active, not recruitingNCT05472402LADIES OnlineUpdated Apr 19, 2024

Feasibility and Acceptability of an Online Program to Promote Physical Activity Among Black Women

An interventional study of LADIES online intervention (R33 phase) and LADIES online control (R33 phase) in Sedentary Behavior, Lack of Physical Activity and Physical Inactivity, sponsored by Gramercy Research Group. Active, not recruiting at 1 site in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-19.

Sponsored by Gramercy Research Group · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Nov 2025, 10 months ago, but the record still lists the study as active, not recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This study will identify strategies for modifying a physical activity intervention, previously delivered in a face-to-face format, for online implementation.

Read the detailed description

Research demonstrates the health-related benefits of participation in daily physical activity (PA), including prevention and treatment of chronic diseases. Despite this knowledge, the majority of US adults, particularly black women, do not achieve recommended levels of PA and, consequently, have higher rates of related chronic disease. An efficacy study led by the proposed Principal Investigator developed and tested an in person, 10-month group-based faith-integrated (FI) or secular (SEC) PA intervention, compared with a self-guided control (SG) for black women. Both FI and SEC were superior to SG for increasing daily steps after 10 months, and FI was superior to SG for increasing daily steps 12 months post intervention. Barriers to program participation noted by participants included childcare and work responsibilities and proximity to the group meeting location. The 2018 PA Guidelines Advisory Committee Scientific Report highlighted the need for effective strategies to promote PA, including internet-delivered interventions which have demonstrated strong evidence for effectiveness at increasing PA levels. Limited data exist regarding the efficacy of internet-delivered interventions in racial/ethnic minority groups. Online delivery of our evidence-based program may increase reach and address known barriers to PA program participation in black women. This project will explore strategies for adapting the program for web-based delivery of the existing curriculum. R21 phase aims are: Aim 1: Solicit input from individuals representative of the population of focus to inform the translation of the FI curriculum for online use; Aim 2: Use the knowledge gathered in Aim 1 to adapt existing FI and SG curricula for online use; Aim 3: Assess acceptability of the online curricula in an advisory group similar to the target population. Investigators will conduct focus groups with black women to understand factors that would influence online delivery of the curriculum. A 12-member advisory group will be convened to assist with developing materials/strategies to adapt the curriculum for online delivery. In an iterative approach where material is tested, refined, and retested until complete, investigators will engage the advisory group in feasibility testing of the online curriculum

02

Conditions studied

  • Sedentary Behavior
  • Lack of Physical Activity
  • Physical Inactivity

Browse trials for

03

In context

Hypokinesia

84 studies on the registry are indexed under Hypokinesia; 10 are open to participants now.

This study's planned enrollment of 60 is close to the median of 60 across 65 interventional studies indexed under Hypokinesia.

Browse Hypokinesia studies →

Lead sponsor

Gramercy Research Group is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

  1. self-identified female
  2. black/African American
  3. > 18 years of age
  4. self-reported low active (i.e., achieving \< 150 minutes per week of moderate-to-vigorous physical activity)
  5. no physical limitations or medical conditions that would be impacted by physical activity
  6. own a smartphone or computer with reliable high speed internet access
  7. able to speak and read English fluently; 8) potentially interested in participating in an online health intervention.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    LADIES online intervention (R33 phase)

    Participants will include 30 women who will be randomized to receive six (6) months of online group-based intervention sessions that teach participants how to increase physical activity levels.

    Behavioral: LADIES online intervention (R33 phase)

  • Placebo comparator
    LADIES online control (R33 phase)

    Participants will include 30 women who will be randomized to receive self-guided materials that teach participants how to increase physical activity levels. Placebo comparator participants will receive their materials via the online platform.

    Behavioral: LADIES online control (R33 phase)

Interventions

  • BehavioralLADIES online intervention (R33 phase)

    Participants will participate weekly online group sessions over 6 months. Participants will also receive access to written intervention materials, access to an online walking program, and access to weekly podcasts that are aligned with the intervention sessions and that support physical activity lessons with biblical scriptures.

    Also known as: LADIES online

  • BehavioralLADIES online control (R33 phase)

    Participants will receive online access to a written self-guided curriculum that is self-paced and teaches participants how to increase physical activity. Participants will be encouraged to complete the self-guided curriculum within 6 months.

06

What researchers measure

Primary outcomes

  1. Daily step counts

    Daily walking over 14 consecutive days

    Time frame: Baseline and immediately post intervention

  2. Bouts of moderate-to-vigorous physical activity

    Daily bouts over 14 consecutive days using a wrist-worn accelerometer

    Time frame: Baseline and immediately post intervention

Secondary outcomes

  1. Sedentary behavior

    Daily bouts over 14 consecutive days using a wrist-worn accelerometer

    Time frame: Baseline and immediately post intervention

  2. Self-reported physical activity

    Participant reported using the 7-item self-administered modifided International Physical Activity Questionnaire

    Time frame: Baseline and immediately post intervention

  3. Clinical measures

    Height, weight, seated blood pressure, waist circumference

    Time frame: Baseline and immediately post intervention

07

Study locations

1 site
  • Gramercy Research Group
    Knightdale, North Carolina 27545, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05472402
Lead sponsor
Gramercy Research Group
Responsible party
Melicia Whitt-Glover (President & CEO, Gramercy Research Group) — Principal investigator
First posted
Jul 25, 2022
Start date
May 22, 2022
Primary completion
Nov 30, 2025 (estimated)
Completion
Nov 30, 2025 (estimated)
Last update
Apr 19, 2024

Study contacts

Melicia Whitt-Glover, PhD
principal investigator · Gramercy Research Group
Robert Newton, PhD
principal investigator · Pennington Biomedical Research Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion